Huang H-C, Hu C-H, Tang M-C, Wang W-S, Chen P-M, Su Y
Institute of Bioscience and Biotechnology, College of Life Science, National Taiwan Ocean University, Keelung, and Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China.
Oncogene. 2007 Apr 26;26(19):2781-90. doi: 10.1038/sj.onc.1210078. Epub 2006 Oct 30.
The epithelial-mesenchymal transition (EMT) is crucial for the invasion and metastasis of many epithelial tumors including colorectal carcinoma (CRC). In the present study, a scattering and fibroblastic morphology with reduced intercellular contacts was found in the SW480 colon cancer cells overexpressing the gene encoding thymosin beta4 (Tbeta4), which was accompanied by a loss of E-cadherin as well as a cytosolic accumulation of beta-catenin, two most prominent markers of EMT. Whereas E-cadherin downregulation was likely to be accounted by a ZEB1-mediated transcriptional repression, the accumulation of beta-catenin was a result of glycogen synthase kinase-3beta inactivation mediated by integrin-linked kinase (ILK) and/or its downstream effector, Akt. Intriguingly, ILK upregulation in Tbeta4-overexpressing SW480 cells seemed to be attributed mainly to a stabilization of this kinase by complexing with particularly interesting new Cys-His protein (PINCH) more efficiently. In the meantime, a strong correlation between the expression levels of Tbeta4, ILK and E-cadherin in CRC patients was also revealed by immunohistochemical analysis. Taken together, these data suggest a novel role of Tbeta4 in promoting CRC progression by inducing an EMT in tumor cells via upregulating ILK and consequentially its signal transduction.
上皮-间质转化(EMT)对于包括结直肠癌(CRC)在内的许多上皮性肿瘤的侵袭和转移至关重要。在本研究中,在过表达编码胸腺素β4(Tβ4)基因的SW480结肠癌细胞中发现了一种具有减少的细胞间接触的散射和成纤维细胞形态,同时伴随着E-钙黏蛋白的丢失以及β-连环蛋白的胞质积累,这是EMT的两个最显著标志。虽然E-钙黏蛋白下调可能是由ZEB1介导的转录抑制引起的,但β-连环蛋白的积累是整合素连接激酶(ILK)和/或其下游效应物Akt介导的糖原合酶激酶-3β失活的结果。有趣的是,在过表达Tβ4的SW480细胞中ILK上调似乎主要归因于该激酶与特别有趣的新Cys-His蛋白(PINCH)更有效地结合而实现的稳定化。同时,免疫组织化学分析也揭示了CRC患者中Tβ4、ILK和E-钙黏蛋白表达水平之间的强相关性。综上所述,这些数据表明Tβ4通过上调ILK及其信号转导从而在肿瘤细胞中诱导EMT来促进CRC进展中发挥新作用。